Agency Information Collection Activities: Proposed Collection; Comments Requested, 17126-17127 [05-6528]
Download as PDF
17126
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6588 Filed 4–1–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on January
5, 2005, Roche Diagnostics Operations
Inc., Attention: Regulatory Compliance,
9115 Hague Road, Indianapolis, Indiana
46250, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in Schedules I and II:
Drug
Schedule
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Cocaine (9041) .............................
Ecgonine (9180) ...........................
Methadone (9250) ........................
Morphine (9300) ...........................
Alphamethadol (9605) ..................
I
I
II
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of diagnostic products for
distribution to its customers.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, D.C. 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than May 4, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6590 Filed 4–1–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on April
27, 2004, Wildlife Laboratories, 1401
Duff Drive, Suite 400, Fort Collins,
Colorado 80524, made application to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Etorphine Hydrochloride (9059), a basic
class of controlled substance listed in
Schedule II.
The company plans to import small
quantities of the listed controlled
substance for the manufacture of
analytical reference standards.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections, or requests for hearing being
sent via regular mail may be addressed,
in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion
Control, Drug Enforcement
Administration, Washington, DC 20537,
Attention: DEA Federal Register
Representative, Liaison and Policy
Section (ODL); or any being sent via
express mail should be sent to DEA
Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401
Jefferson Davis Highway, Alexandria,
Virginia 22301; and must be filed no
later than May 4, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance in Schedule I
or II are, and will continue to be
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6593 Filed 4–1–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
30-day notice of information
collection under review: promising
programs for substance abuse
prevention: replication and evaluation
initiative.
ACTION:
The Department of Justice (DOJ),
Office of Justice Programs (OJP) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
E:\FR\FM\04APN1.SGM
04APN1
Federal Register / Vol. 70, No. 63 / Monday, April 4, 2005 / Notices
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register, Volume 69, Number 235, page
71074 on December 8, 2004, allowing
for a 60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until May 4, 2005. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention: Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
New Collection.
(2) Title of the Form/Collection:
Promising Programs for Substance
Abuse Prevention: Replication and
Evaluation Initiative.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
There is no agency form number. Office
of Juvenile Justice and Delinquency
VerDate jul<14>2003
15:19 Apr 01, 2005
Jkt 205001
17127
Prevention, United States Department of
Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals. Other:
Not-for profit. Two substance abuse
prevention programs for middle school
and alternative high school students
will be evaluated for effectiveness by
independent evaluators, potentially
establishing them as effective programs.
Middle schools and high schools will be
asked to assist in study implementation.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 7,000
respondents will complete a 35–40
minute survey three times (pre-test,
post-test, and one-year follow-up posttest) over the next four years.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated total burden to
complete the nominations is 12, 600
hours. The average annual hour burden
(over four years) is 3,150.
If additional information is required
contact: Brenda E. Dyer, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
FOR FURTHER INFORMATION CONTACT:
Brenda E. Dyer,
Department Clearance Officer, Department of
Justice.
[FR Doc. 05–6528 Filed 4–1–05; 8:45 am]
This meeting is open to the public.
Due to security measures, however,
members of the public who wish to
attend this meeting must register with
Mr. J. Patrick McCreary, at the above
address, at least (7) days in advance of
the meeting. Registrations will be
accepted on a space available basis.
Access to the meeting will not be
allowed without registration. All
attendees will be required to sign in at
the meeting registration desk. Please
bring photo identification and allow
extra time prior to the meeting.
Anyone requiring special
accommodations should notify Mr.
McCreary at least seven (7) days in
advance of the meeting.
Interested persons whose registrations
have been accepted may be permitted to
participate in the discussions at the
discretion of the meeting chairman and
with approval of the DFE.
BILLING CODE 4410–18–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (OJP)–1416]
Meeting of the Global Justice
Information Sharing Initiative Federal
Advisory Committee
Office of Justice Programs,
Justice.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: This is an announcement for
a meeting of the Global Justice
Information Sharing Initiative Federal
Advisory Committee (GAC) to discuss
the Global Initiative, as described at
https://www.it.ojp.gov/global.
DATES: The meeting will take place on
Wednesday, April 27, 2005, from 1 p.m.
to 5 p.m. ET, and Thursday, April 28,
2005, from 8:30 a.m. to 12 noon ET.
ADDRESSES: The meeting will take place
at the Wyndham Washington, DC, 1400
M Street, NW., Washington, DC 20005;
Phone: (202) 429–1700.
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
J.
Patrick McCreary, Global Designated
Federal Employee (DFE), Bureau of
Justice Assistance, Office of Justice
Programs, 810 7th Street, Washington,
DC 20531; phone: (202) 616–0532 (note:
this is not a toll-free number); e-mail:
James.P.McCreary@usdoj.gov.
SUPPLEMENTARY INFORMATION:
Purpose
The GAC will act as the focal point for
justice information systems integration
activities in order to facilitate the
coordination of technical, funding, and
legislative strategies in support of the
Administration’s justice priorities.
The GAC will guide and monitor the
development of the Global Information
Sharing concept. It will advise the
Assistant Attorney General, OJP; the
Attorney General; the President
(through the Attorney General); and
local, State, tribal, and Federal
policymakers in the executive,
legislative, and judicial branches. The
GAC will also act as an advocate of
strategies for accomplishing Global
information sharing capability.
Meeting Registration and
Accommodation
J. Patrick McCreary,
Global DFE, Bureau of Justice Assistance,
Office of Justice Programs.
[FR Doc. 05–6583 Filed 4–1–05; 8:45 am]
BILLING CODE 4410–18–P
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Pages 17126-17127]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-65]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Office of Justice Programs
Agency Information Collection Activities: Proposed Collection;
Comments Requested
ACTION: 30-day notice of information collection under review: promising
programs for substance abuse prevention: replication and evaluation
initiative.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Office of Justice Programs (OJP)
has submitted the following information collection request to the
Office of Management and Budget (OMB) for review and approval in
accordance with
[[Page 17127]]
the Paperwork Reduction Act of 1995. The proposed information
collection is published to obtain comments from the public and affected
agencies. This proposed information collection was previously published
in the Federal Register, Volume 69, Number 235, page 71074 on December
8, 2004, allowing for a 60-day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until May 4, 2005. This process is conducted in
accordance with 5 CFR 1320.10.
Written comments and/or suggestions regarding the items contained
in this notice, especially the estimated public burden and associated
response time, should be directed to the Office of Management and
Budget, Office of Information and Regulatory Affairs, Attention:
Department of Justice Desk Officer, Washington, DC 20503. Additionally,
comments may be submitted to OMB via facsimile to (202) 395-5806.
Written comments and suggestions from the public and affected agencies
concerning the proposed collection of information are encouraged. Your
comments should address one or more of the following four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of This Information Collection
(1) Type of Information Collection: New Collection.
(2) Title of the Form/Collection: Promising Programs for Substance
Abuse Prevention: Replication and Evaluation Initiative.
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection: There is no agency form number.
Office of Juvenile Justice and Delinquency Prevention, United States
Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Individuals. Other: Not-for profit.
Two substance abuse prevention programs for middle school and
alternative high school students will be evaluated for effectiveness by
independent evaluators, potentially establishing them as effective
programs. Middle schools and high schools will be asked to assist in
study implementation.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond/reply: It is
estimated that 7,000 respondents will complete a 35-40 minute survey
three times (pre-test, post-test, and one-year follow-up post-test)
over the next four years.
(6) An estimate of the total public burden (in hours) associated
with the collection: The estimated total burden to complete the
nominations is 12, 600 hours. The average annual hour burden (over four
years) is 3,150.
If additional information is required contact: Brenda E. Dyer,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Brenda E. Dyer,
Department Clearance Officer, Department of Justice.
[FR Doc. 05-6528 Filed 4-1-05; 8:45 am]
BILLING CODE 4410-18-P